|
|
|
TCTAP 2017 Press Kit |
|
TCTAP 2016 Final Program |
|
Introduction of CVRF |
|
|
|
|
TCTAP 2016 Sponsor |
OrbusNeich Medical Korea |
OrbusNeich is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. Current products are the world's first dual therapy stent, the COMBO¢â Dual Therapy Stent, and the world¡¯s first pro-healing stent, the Genous¢â Stent. Other products include stents and balloons marketed under the names of Azule¢â, Scoreflex¢â, Sapphire¢â II, Sapphire¢â II Pro and Sapphire¢â II NC. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Florida, USA.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich supplies medical devices to interventional cardiologists in more than 60 countries.
Booth No. A006
|
Lunchtime Activities |
New Technologies That Maximize Procedural Outcome and Long-Term Benefits |
Organized by CVRF and Supported by Educational Grant from OrbusNeich Medical Co., Ltd. |
Thursday, April 28
12:45 PM - 1:40 PM
The Latest Update "Presentation Theater", Level 1 |
Moderator(s): Myung-Ho Jeong, Soo-Teik Lim | Panelist(s): Woong Chol Kang, Soo-Joong Kim | |
12:45 PM |
Opening Address
Speaker : Soo-Teik Lim
|
12:50 PM |
The Newest Balloon Technology for Tackling the Most Challenging CTO Cases
Lecturer : Toshiya Muramatsu
|
1:00 PM |
Panel Discussion
|
1:05 PM |
Can Lesion Preparation with Scoring Balloons Improve Clinical Results?
Lecturer : Jack Wei Chieh Tan
|
1:15 PM |
Panel Discussion
|
1:20 PM |
EPC Capture Stent : A Promising Solution Amongst the DAPT Controversy?
Lecturer : Roxana Mehran
|
1:35 PM |
Panel Discussion
|
1:40 PM |
Closing Remarks
Speaker : Myung-Ho Jeong
|
|
|
|
|
|